Together, these findings emphasize that copy number dysregulation acts as a critical secondary driver of EwS biology, shaping tumor evolution, buffering fusion-induced stress, and influencing clinical outcome advantage (see Table 1 for representative CNAs and mechanistic context) [59]. This evidence concerns the gene EWSR1 and neoplasm.